Pia Mountford

Head of External Manufacturing, Cell and Genetic Therapies at Vertex Pharmaceuticals

Speaker

Pia Mountford heads up Vertex Pharmaceuticals’ External Manufacturing group for Cell and Genetic Therapies. After 18 years at Bristol Myers-Squib in various roles, including MSAT, Operations, Strategic Sourcing and Product Strategy, Pia joined the world of CGT. At Juno/Celgene, her responsibilities included management of external CDMOs for the viral vectors associated with that company’s CAR-T programs. A move to CRISPR Therapeutics allowed a deeper involvement in the CRISPR/Cas9 gene-editing autologous and allogeneic programs. The alliance between CRISPR Therapeutics and Vertex for the exagamglogene autotemcel program was the perfect opportunity for Pia to help lead the late-stage clinical program execution and prepare for commercialization of the product.